Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Bell

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|January 13, 2001
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancerP Seth, K L Lunetta, D W Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's diseaseK E Nichols, S Levitz, K E Shannon, et al.
International Journal of Cancer|August 22, 1995
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasA Bellacosa, D de Feo, A K Godwin, et al.
Science (New York, N.Y.)|January 5, 2000
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndromeD W Bell, J M Varley, T E Szydlo, et al.
Cancer Research|November 24, 2001
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni SyndromeS B Lee, S H Kim, D W Bell, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|January 13, 2001
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancerP Seth, K L Lunetta, D W Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's diseaseK E Nichols, S Levitz, K E Shannon, et al.
International Journal of Cancer|August 22, 1995
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasA Bellacosa, D de Feo, A K Godwin, et al.
Science (New York, N.Y.)|January 5, 2000
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndromeD W Bell, J M Varley, T E Szydlo, et al.
Cancer Research|November 24, 2001
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni SyndromeS B Lee, S H Kim, D W Bell, et al.
Pageof 5